Form 144 BIO-RAD LABORATORIES, Filed by: Alles Institute for Medical Research Corp

Thu, 28 May 2026 15:04:00 -0400

si-local-file:///var/storage/secattach/20260528/26565828.html

Form 144 BIO-RAD LABORATORIES, Filed by: Alles Institute for Medical Research Corp

Thu, 28 May 2026 15:04:00 -0400

si-local-file:///var/storage/secattach/20260528/26565828.html

Elliott to engage Bio-Rad on ways to boost stock price - Bloomberg

Wed, 20 May 2026 15:00:48 -0400

Elliott to engage Bio-Rad on ways to boost stock price - Bloomberg

Wed, 20 May 2026 15:00:48 -0400

Elliott to engage Bio-Rad on ways to boost stock price - Bloomberg

RBC Capital Assumes Bio-Rad Labs (BIO) at Outperform

Thu, 14 May 2026 16:27:17 -0400

(Updated - May 14, 2026 4:27 PM EDT)

RBC Capital analyst Dan Leonard assumes coverage on Bio-Rad Labs (NYSE: BIO) with a Outperform rating and a price target of $320.00.

The analyst comments "We resume coverage of Bio-Rad (BIO) with an Outperform rating and $320 price target, which reflects our view that its sales growth should recover in 2027 following idiosyncratic product headwinds (e.g., process chromatography), and new management will embark on efforts to structurally improve Bio-Rad's margin profile. Moreover, the optionality associated with Bio-Rad's monetizable 33% ownership stake in Sartorius should increase once the Sartorius Trust terminates in mid-2028."

For an analyst

Form SD BIO-RAD LABORATORIES,

Wed, 13 May 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260513/26486682.html

Form SD BIO-RAD LABORATORIES,

Wed, 13 May 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260513/26486682.html

Form 4 BIO-RAD LABORATORIES, For: May 11 Filed by: ENGELHARDT EVA ANETTE

Wed, 13 May 2026 15:38:00 -0400

si-local-file:///var/storage/secattach/20260513/26485481.html

Form 4 BIO-RAD LABORATORIES, For: May 11 Filed by: ENGELHARDT EVA ANETTE

Wed, 13 May 2026 15:38:00 -0400

si-local-file:///var/storage/secattach/20260513/26485481.html

Form 4 BIO-RAD LABORATORIES, For: May 11 Filed by: ENGELHARDT EVA ANETTE

Wed, 13 May 2026 15:38:00 -0400

si-local-file:///var/storage/secattach/20260513/26485481.html

Form 144 BIO-RAD LABORATORIES, Filed by: ENGELHARDT EVA ANETTE

Mon, 11 May 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260511/26470407.html

Form 144 BIO-RAD LABORATORIES, Filed by: ENGELHARDT EVA ANETTE

Mon, 11 May 2026 17:03:00 -0400

si-local-file:///var/storage/secattach/20260511/26470407.html

Bio-Rad to Participate in Upcoming Investor Conferences

Fri, 08 May 2026 09:00:00 -0400

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences:

2026 RBC Capital Markets Global Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Participants: Roop K. Lakkaraju, Chief Financial Officer
Date and Time: Tuesday, May 19, 2026, at 8:30 AM Eastern Time; a live webcast and subsequent replay of the fireside chat event will be available in the Investor Relations section of Bio-Rad’s website at